Literature DB >> 10672014

Complementation of NADPH oxidase in p67-phox-deficient CGD patients p67-phox/p40-phox interaction.

S Vergnaud1, M H Paclet, J El Benna, M A Pocidalo, F Morel.   

Abstract

Chronic granulomatous disease (CGD) is due to a functional defect of the O2- generating NADPH oxidase of phagocytes. Epstein-Barr-virus-immortalized B lymphocytes express all the constituents of oxidase with activity 100 times less than that of neutrophils. As in neutrophils, oxidase activity of Epstein-Barr-virus-immortalized B lymphocytes was shown to be defective in the different forms of CGD; these cells were used as a model for the complementation studies of two p67-phox-deficient CGD patients. Reconstitution of oxidase activity was performed in vitro by using a heterologous cell-free assay consisting of membrane-suspended or solubilized and purified cytochrome b558 that was associated with cytosol or with the isolated cytosolic-activating factors (p67-phox, p47-phox, p40-phox) from healthy or CGD patients. In p67-phox-deficient CGD patients, two cytosolic factors are deficient or missing: p67-phox and p40-phox. Not more than 20% of oxidase activity was recovered by complementing the cytosol of p67-phox-deficient patients with recombinant p67-phox. On the contrary, a complete restoration of oxidase activity was observed when, instead of cytosol, the cytosolic factors were added in the cell-free assay after isolation in combination with cytochrome b558 purified from neutrophil membrane. Moreover, the simultaneous addition of recombinant p67-phox and recombinant p40-phox reversed the previous complementation in a p40-phox dose-dependent process. These results suggest that in the reconstitution of oxidase activity, p67-phox is the limiting factor; the efficiency of complementation depends on the membrane tissue and the cytosolic environment. In vitro, the transition from the resting to the activated state of oxidase, which results from assembling, requires the dissociation of p40-phox from p67-phox for efficient oxidase activity. In the process, p40-phox could function as a negative regulatory factor and stabilize the resting state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672014     DOI: 10.1046/j.1432-1327.2000.01097.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

1.  Regulation of NADPH oxidase activity in phagocytes: relationship between FAD/NADPH binding and oxidase complex assembly.

Authors:  Franck Debeurme; Antoine Picciocchi; Marie-Claire Dagher; Didier Grunwald; Sylvain Beaumel; Franck Fieschi; Marie-José Stasia
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

Review 2.  NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?

Authors:  Joanna Wieczfinska; Milena Sokolowska; Rafal Pawliczak
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

3.  New p22-phox monoclonal antibodies: identification of a conformational probe for cytochrome b 558.

Authors:  Yannick Campion; Algirdas J Jesaitis; Minh Vu Chuong Nguyen; Alexei Grichine; Yvan Herenger; Athan Baillet; Sylvie Berthier; Françoise Morel; Marie-Hélène Paclet
Journal:  J Innate Immun       Date:  2009-07-29       Impact factor: 7.349

4.  Characterization of superoxide overproduction by the D-Loop(Nox4)-Nox2 cytochrome b(558) in phagocytes-Differential sensitivity to calcium and phosphorylation events.

Authors:  Laure Carrichon; Antoine Picciocchi; Franck Debeurme; Federica Defendi; Sylvain Beaumel; Algirdas J Jesaitis; Marie-Claire Dagher; Marie-José Stasia
Journal:  Biochim Biophys Acta       Date:  2010-08-11

5.  Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.

Authors:  Marie José Stasia; Pierre Bordigoni; Daniel Floret; Jean Paul Brion; Cécile Bost-Bru; Gérard Michel; Pierre Gatel; Denis Durant-Vital; Marie Antoinette Voelckel; Xing Jun Li; Michèle Guillot; Elisabeth Maquet; Cécile Martel; Françoise Morel
Journal:  Hum Genet       Date:  2004-11-06       Impact factor: 4.132

6.  A regulated adaptor function of p40phox: distinct p67phox membrane targeting by p40phox and by p47phox.

Authors:  Takehiko Ueyama; Toshihiko Tatsuno; Takumi Kawasaki; Satoshi Tsujibe; Yasuhito Shirai; Hideki Sumimoto; Thomas L Leto; Naoaki Saito
Journal:  Mol Biol Cell       Date:  2006-11-22       Impact factor: 4.138

7.  Functional and genetic characterization of two extremely rare cases of Williams-Beuren syndrome associated with chronic granulomatous disease.

Authors:  Marie J Stasia; Michèle Mollin; Cécile Martel; Véronique Satre; Charles Coutton; Florence Amblard; Gaëlle Vieville; Joris M van Montfrans; Jaap J Boelens; Hermine E Veenstra-Knol; Karen van Leeuwen; Martin de Boer; Jean-Paul Brion; Dirk Roos
Journal:  Eur J Hum Genet       Date:  2013-01-23       Impact factor: 4.246

Review 8.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.

Authors:  Andrew R Cross; Anthony W Segal
Journal:  Biochim Biophys Acta       Date:  2004-06-28

9.  First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.

Authors:  Faris G Bakri; Cécile Martel; Najwa Khuri-Bulos; Azmi Mahafzah; Mohammad S El-Khateeb; Adel M Al-Wahadneh; Wail A Hayajneh; Hanan A Hamamy; Elisabeth Maquet; Michelle Molin; Marie José Stasia
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

10.  Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.

Authors:  Cécile Martel; Michelle Mollin; Sylvain Beaumel; Jean Paul Brion; Charles Coutton; Véronique Satre; Gaëlle Vieville; Mary Callanan; Christine Lefebvre; Alexandra Salmon; Anne Pagnier; Dominique Plantaz; Cécile Bost-Bru; Laurence Eitenschenck; Isabelle Durieu; Daniel Floret; Claire Galambrun; Hervé Chambost; Gérard Michel; Jean-Louis Stephan; Olivier Hermine; Stéphane Blanche; Nathalie Blot; Hervé Rubié; Guillaume Pouessel; Stephanie Drillon-Haus; Bernard Conrad; Klara M Posfay-Barbe; Zuzana Havlicekova; Tamara Voskresenky-Baricic; Kelecic Jadranka; Maria Cristina Arriazu; Luis Alberto Garcia; Lamia Sfaihi; Lamia Sfaihi Ben Mansour; Pierre Bordigoni; Marie José Stasia
Journal:  J Clin Immunol       Date:  2012-05-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.